Mr. Schwartz is a partner in the Competition & Antitrust Department and the Litigation Department. He specializes in competition & antitrust practices, litigation, and commercial disputes.
Mr. Schwartz represents clients in civil lawsuits and arbitration, including class actions, damages claims and proceedings before the Competition Tribunal and the Supreme Court.
Mr. Schwartz also provides legal advice with respect to competition and antitrust matters relating to merger control, restrictive trade practices cartels, dominance and monopoly, joint ventures, distribution agreements; and the creation and implementation of internal compliance programs. He also advises clients with respect to administrative and criminal investigations.
Mr. Schwartz also has substantial experience with regards to the Israeli Concentration Law, the Food Law, and other competition related legislation and regulation.
Mr. Schwartz appears in the 2022 edition of Globes ‘40 Under 40’; the 2020 edition of Global Competition Review’s ‘40 Under 40’; and in the 2017 - 2021 editions of Who’s Who Legal Competition: Future Leaders. He is also ranked as a Leading Individual by The Legal 500 and by Chambers.
Mr. Schwartz is recognized as a "Future Leader" by Who’s Who Legal; and was praised by Chambers for his “experience in merger control matters before the ICA”, and for being “regularly featured on major competition litigation cases, including class actions ".
Mr. Schwartz received his LL.M. degree from Columbia University School of Law, where he was named a Harlan Fiske Stone Scholar. During his studies, Mr. Schwartz served as a research assistant and was a member of the editorial board of the Columbia Business Law Review.
Competition & Antitrust
Competition & Antitrust
Competition & Antitrust
Globes ’40 Under 40′ Promising Leadership Team for 2022
GCR100 ’40 Under 40′ – Competition & Antitrust
Columbia University School of Law, New York, LL.M. (Harlan Fiske Stone Scholar), 2012
Tel Aviv University, LL.B. (Magna Cum Laude) (Dean’s List), 2007
Tel Aviv University, B.A. (Communications), 2007
A merger in the in private healthcare field We were happy to advise Medica Excel Tel Aviv Ltd. and Harel Investments in an agreement in which Medica purchased from Harel 50% of Raphael Hospital Ltd., located in Ramat HaHayal, Tel Aviv. The transaction is subject t...Michal Nissani Josefson & Ziv Schwartz & Udi Fogel | Feb 2023
A significant deal in the field of insurance agencies! Congratulations to our firm’s client, Alifim Insurance Agency (2002) Ltd., on the sale of 50% of the company to Menora Mivtachim Insurance Ltd. for NIS 140 million, according to media reports. The deal valuates Al...Michal Nissani Josefson & Ziv Schwartz & Moran Friedman & Hila Zackay | Apr 2022
An iconic acquisition! Congrats to our client, Icon Group Ltd. (iDigital), for entering into an acquisition agreement of the control of VISUAL D.G. Ltd. at a company value of approx. NIS 80 million, according to media reports. VISUAL specializes in providing advanced ...Sharon Klein-Manbar & Raz Tepper & Ziv Schwartz & Sharon Madel-Artzy & Amit Bechler & Hila Karmona & Shahaf Kazelnik | Mar 2022
La Dolce Vita Way of Life Congratulations to our client Sky Fund for the acquisition of 50% of the shares of Dolce Vita Way of Life Ltd. at a company value of approximately NIS 220 million, according to media reports. This is the first acquisition by Sky 4 Private Equi...Raz Tepper & Shmulik Fried & Ziv Schwartz & Omri Rachum-Twaig, Dr. & Ben Strauss & Hilla Sachs | Mar 2022
Mega deal right out of the gate in 2022! We are excited to share that our firm has had the honor of representing our long-standing client, Tower Semiconductor Ltd., the Israeli chipmaker, in its acquisition by Intel, at a value of $5.4 billion (!) This deal is one of ...Avraham Well & Sharon Rosen & Ron Sitton & Yuval Peled & Tal Eyal-Boger & Ziv Schwartz & Moran Friedman & Etti Dolev & Omri Rachum-Twaig, Dr. & Audrey Abensur & Yahel Arckens | Mar 2022
Representation of Luminera Derm Ltd. and its affiliated companies in a share and asset transaction, pursuant to which Luminera sold its dermal filler portfolio and R&D pipeline to AbbVie Inc. (NYSE: ABBV) unit Allergan Aesthetics, for a consideration of hundreds of ...Raz Tepper & Sharon Klein-Manbar & Anat Shavit & Ziv Schwartz & Sharona Haim Pour - Abramovich & Yuval Peled & Ben Strauss & Hila Zackay & Audrey Abensur & Moran Friedman | Oct 2020
משרדנו ייצג את ג'נריישן קפיטל בע"מ ב עסקה לרכישת 50% מהון המניות המונפק של דקל תשתיות (2001) בע"מ, והמחאה של 50% מהלוואות הבעלים בה, מידי י.ש. אחים יעקובי בע"מ, בתמורה לסך כולל של 60.1 מיליון ש"ח. עובר לחתימת העסקה העמידה ג'נריישן קפיטל לקבוצת יעקובי הלוואה בסך 15 מילי...Avraham Well & Hadar Sive & Ziv Schwartz | Sep 2020